LA Private

November 15, 2024

Growth ahead: Aspen upgrades FY25 outlook on development boom

Aspen Group (ASX:APZ), a property investment and management company specialising in affordable housing and lifestyle communities, has upgraded its earnings guidance for FY25. The company now expects underlying earnings per security (EPS) to reach 16.0 cents, a 5% increase over previous forecasts and a 16% rise from FY24’s 13.8 cents. Aspen attributes the earnings upgrade

Growth ahead: Aspen upgrades FY25 outlook on development boom Read More »

Charging down: Trump team to scrap tax credit – with Tesla’s support

President-elect Donald Trump’s transition team is planning to eliminate the $7,500 federal tax credit for electric vehicle (EV) purchases, a move that could hinder EV adoption across the United States. According to sources cited by Reuters, Trump’s energy transition team, led by billionaire oilman Harold Hamm and North Dakota Governor Doug Burgum, views this tax

Charging down: Trump team to scrap tax credit – with Tesla’s support Read More »

Stocks of the Hour: Lendlease, APA Group, Altech Batteries

To register for today’s webinar click here. Lendlease (ASX:LLC), a major construction and investment firm, is in the spotlight this week as its annual general meeting concluded. Shareholders heard a cautious outlook for the coming year, with ongoing struggles in the construction arm stemming from pandemic-era projects and rising costs. While the company refrained from

Stocks of the Hour: Lendlease, APA Group, Altech Batteries Read More »

ASX files defence in ASIC proceedings

ASX (ASX:ASX) filed its defence today in relation to proceedings initiated by the Australian Securities and Investments Commission (ASIC). In mid-August, ASIC claimed in an application to the Federal Court that ASX had misled investors. ASIC alleged that, in February 2022, ASX incorrectly stated that the planned blockchain-based upgrade to the company’s Clearing House Electronic Subregister

ASX files defence in ASIC proceedings Read More »

Eye on the prize: $15.9m boost for Opthea’s vision impairment therapy

Opthea (ASX:OPT), a clinical-stage biopharmaceutical company based in Melbourne, has announced a boost to its cash reserves, receiving a $15.9m research and development (R&D) tax incentive from the Australian Taxation Office. The funding supports Opthea’s development of sozinibercept, an innovative therapy targeting wet age-related macular degeneration (wet AMD), one of the leading causes of severe

Eye on the prize: $15.9m boost for Opthea’s vision impairment therapy Read More »

Otago’s golden future: Santana’s PFS forecasts $1bn NPV

Santana Minerals (ASX:SMI) has released its Pre-Feasibility Study (PFS) results for the Bendigo-Ophir Gold Project in New Zealand’s Otago region, showcasing a high-margin, long-life gold development with low capital costs. The study estimates that the project, encompassing both open-pit and underground mining, will yield 1.15 million ounces of gold over a 9.2-year lifespan, with an

Otago’s golden future: Santana’s PFS forecasts $1bn NPV Read More »